Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma

European Radiology

Volumn 27, Issue 8, 2017, Pages 3509-3522

  Yu, Jinhua ^a,b   Shi, Zhifeng ^c   Lian, Yuxi ^a   Li, Zeju ^a   Liu, Tongtong ^a   Gao, Yuan ^a   Wang, Yuanyuan ^a   Chen, Liang ^c   Mao, Ying ^c  

^a FUDAN UNIVERSITY   (China)

^b State Key Laboratory of Medical Genomics   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Grade II glioma; Isocitrate dehydrogenase 1; Magnetic resonance imaging; Noninvasive biomarker estimation; Radiomics

Indexed keywords

ISOCITRATE DEHYDROGENASE 1; IDH1 PROTEIN, HUMAN; ISOCITRATE DEHYDROGENASE; TUMOR MARKER; TUMOR PROTEIN;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; CANCER DIAGNOSIS; CANCER GRADING; CANCER LOCALIZATION; CHILD; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FRONTAL LOBE; GENE MUTATION; GENETIC ALGORITHM; GLIOMA; HUMAN; IMAGE SEGMENTATION; INSULA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; OLIGODENDROGLIOMA; PARIETAL LOBE; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; TEMPORAL LOBE; AGED; BRAIN TUMOR; COHORT ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; GENETICS; INFANT; MIDDLE AGED; MUTATION; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; PROCEDURES; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GLIOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INFANT; INFANT, NEWBORN; ISOCITRATE DEHYDROGENASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; NEOPLASM GRADING; NEOPLASM PROTEINS; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 85006922665     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-016-4653-3     Document Type: Article

References (36)

1. Patrick YW, Santosh K (2008) Malignant Gliomas in Adults. N Engl J Med. doi:10.1056/NEJMra0708126
2. Wang Q, Zhang H, Zhang J et al (2016) The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis. Eur Radiol. doi:10.1007/s00330-015-4046-z
3. Venneti S, Huse JT (2015) The evolving molecular genetics of low-grade glioma. Adv Anat Pathol. doi:10.1097/PAP.0000000000000049
4. Brat DJ, Verhaak RG, Aldape KD et al (2015) Comprehensive. Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. doi:10.1056/NEJMoa1402121
5. Weller M, Pfister SM, Wick W, Hegi ME, Reifenberger G, Stupp R (2013) Molecular neuro-oncology in clinical practice: a new horizon. Lancet Oncol. doi:10.1016/S1470-2045(13)70168-2
6. Beiko J, Suki D, Hess KR et al (2014) IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Neuro Oncol. doi:10.1093/neuonc/not159
7. Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. doi:10.1038/ncomms5006
8. Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: Images Are More than Pictures. They Are Data. Radiology. doi:10.1148/radiol.2015151169
9. Vallières M, Freeman CR, Skamene SR, El Naqa I (2015) A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities. Phys Med Biol. doi:10.1088/0031-9155/60/14/5471
10. Wu W, Parmar C, Grossmann P et al (2016) Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology. Front Oncol. doi:10.3389/fonc.2016.00071
11. Cameron A, Khalvati F, Haider M, Wong A (2015) MAPS: A Quantitative Radiomics Approach for Prostate Cancer Detection. IEEE Trans Biomed Eng. doi:10.1109/TBME.2015.2485779
12. Wang J, Kato F, Oyama-Manabe N et al (2015) Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study. PLoS One. doi:10.1371/journal.pone.0143308
13. Parmar C, Grossmann P, Rietveld D, Rietbergen MM, Lambin P, Aerts HJ (2015) Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer. Front Oncol. doi:10.3389/fonc.2015.00272
14. Chan AK, Yao Y, Zhang Z et al (2015) TERT promoter mutations contribute to subset prognostication of lower-grade gliomas. Mod Pathol. doi:10.1038/modpathol.2014.94
15. Pereira S, Pinto A, Alves V, Silva CA (2016) Brain Tumor Segmentation using Convolutional Neural Networks in MRI Images. IEEE Trans Med Imaging. doi:10.1109/TMI.2016.2538465
16. Wechsler-Reya R, Scott MP (2001) The developmental biology of brain tumors. Annu Rev Neurosci. doi:10.1146/annurev.neuro.24.1.385
17. Mazziotta J, Toga A, Evans A et al (2001) A probabilistic atlas and reference system for the human brain. International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci. doi:10.1098/rstb.2001.0915
18. Ellingson BM, Cloughesy TF, Pope WB et al (2012) Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: a radiographic study in 358 de novo human glioblastomas. Neuroimage. doi:10.1016/j.neuroimage.2011.09.076
19. Wang YY, Zhang T, Li SW et al (2015) Mapping p53 mutations in low-grade glioma: a voxel-based neuroimaging analysis. AJNR Am J Neuroradiol. doi:10.3174/ajnr.A4065
20. Wang Y, Zhang T, Li S et al (2015) Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel-based radiographic study of 146 low-grade gliomas. Eur J Neurol. doi:10.1111/ene.12578
21. Tzourio-Mazoyer N, Landeau B, Papathanassiou D et al (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. doi:10.1006/nimg.2001.0978
22. Collewet G, Strzelecki M, Mariette F (2004) Influence of MRI acquisition protocols and image intensity normalization methods on texture classification. Magn Reson Imaging. doi:10.1016/j.mri.2003.09.001
23. Haralick RM, Shanmugam K, Dinstein I (1990) Textural features for image classification. IEEE Trans Syst Man Cybern B Cybern. doi:10.1109/TSMC.1973.4309314
24. Deb K, Pratap A, Agarwal S, Meyarivan T (2002) A fast and elitist multiobjective genetic algorithm: NSGA-II. IEEE TransEvolutComput. doi:10.1109/4235.996017
25. Peng H, Long F, Ding C (2005) Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy. IEEE Trans Pattern Anal Mach Intell. doi:10.1109/TPAMI.2005.159
26. Cortes C, Vapnik V (1995) Support-vector networks. Mach Learn. doi:10.1007/BF00994018
27. Nouretdinov I, Costafreda SG, Gammerman A et al (2011) Machine learning classification with confidence: application of transductive conformal predictors to MRI-based diagnostic and prognostic markers in depression. Neuroimage. doi:10.1016/j.neuroimage.2010.05.023
28. Schapire RE, Singer Y (1999) Improved Boosting Algorithms Using Confidence-rated Predictions. Mach Learn. doi:10.1145/279943.279960
29. Maglietta R, Amoroso N, Boccardi M et al (2016) Automated hippocampal segmentation in 3D MRI using random undersampling with boosting algorithm. Pattern Anal Appl. doi:10.1007/s10044-015-0492-0
30. La Fuente MI, Young RJ, Rubel J et al (2016) Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma. Neuro Oncol. doi:10.1093/neuonc/nov307
31. Lombardi G, Corona G, Bellu L et al (2015) Diagnostic value of plasma and urinary 2-hydroxyglutarate to identify patients with isocitrate dehydrogenase-mutated glioma. Oncologist. doi:10.1634/theoncologist.2014-0266
32. Pope WB, Prins RM, Albert Thomas M et al (2012) Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. J Neurooncol. doi:10.1007/s11060-011-0737-8
33. Andronesi OC, Rapalino O, Gerstner E et al (2013) Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate. J Clin Invest. doi:10.1172/JCI67229
34. Togao O, Hiwatashi A, Yamashita K et al (2016) Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging. Eur Radiol. doi:10.1007/s00330-016-4328-0
35. LLee S, Choi SH, Ryoo I et al (2015) Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging. J Neurooncol. doi:10.1007/s11060-014-1614-z
36. Yamashita K, Hiwatashi A, Togao O et al (2016) MR Imaging-Based Analysis of Glioblastoma Multiforme: Estimation of IDH1 Mutation Status. AJNR Am J Neuroradiol. doi:10.3174/ajnr.A4491